by MH Team | Sep 23, 2025 | Transfusion Medicine
Key Takeaways A Delayed Hemolytic Transfusion Reaction (DHTR) is an immune-mediated adverse event that occurs as a consequence of a blood transfusion. Its defining characteristic is the delayed onset, with signs and symptoms typically appearing 3 to 30 days...
by MH Team | Sep 18, 2025 | Red Blood Cells
Key Takeaways Microangiopathic hemolytic anemia or MAHA is a syndrome defined by a triad of microangiopathic damage, hemolytic anemia, and thrombocytopenia, all resulting from the physical fragmentation of red blood cells in small blood vessels. Pathophysiology...
by MH Team | Sep 16, 2025 | Red Blood Cells
Key Takeaways Pancytopenia is the reduction of all three major blood cell lines: red blood cells (anemia), white blood cells (leukopenia), and platelets (thrombocytopenia). It is a clinical finding, not a disease itself, indicating an underlying issue. Causes ▾...
by MH Team | Sep 13, 2025 | Red Blood Cells
Key Takeaways Shwachman-Diamond syndrome or SDS is a rare, autosomal recessive genetic disorder caused by a mutation in the SBDS gene on chromosome 7. Cause ▾: Shwachman-Diamond Syndrome (SDS) is a rare, inherited genetic disorder. It is an autosomal recessive...
by MH Team | Sep 11, 2025 | Red Blood Cells
Key Takeaways Bone marrow failure is the inability of the bone marrow to produce enough mature blood cells, leading to low counts (pancytopenia). Causes ▾: The causes are broadly divided into acquired and inherited. Acquired causes include immune-mediated...
Recent Comments